格隆汇11月18日丨熵基科技(301330.SZ)公布，公司一直深耕多模态BioCV与AIoT领域，通过旗下熵云 脑机科技持续推进脑机交互技术创新。从虹膜识别、眼动追踪及脑电分析算法领域，熵基已构建起"硬 件+软件+服务"一体化生态，公司在泰国全球大会上也展示了涵盖脑环、脑控无人机、脑电安全帽、专 注力提升系统等脑机创新产品矩阵，为技术场景化落地提供成熟的硬件载体与服务能力。 ...

证券之星消息，2025年11月17日熵基科技（301330）发布公告称公司于2025年11月17日接受机构调研，中 邮证券、建信基金、招商信诺、汐泰投资参与。 具体内容如下： 问：龙之源收购进展情况？ 答：熵基科技于 10 月 17 日公告与龙之源签署《收购意向协议》，目前对方正在变更公司持股比例，预计 会在 11 月底前完成，变更完成后熵基科技将持有龙之源 55%的股权并合并报表。 问：公司脑机接口布局情况？ 答：公司脑机技术聚焦教育、医疗、养老三大核心应用场景，运用 I驱动的多模态数据融合技术，围绕分 析诊断、检测辅助康复、治疗三大方向开展产品研发。在智慧教育领域，公司通过开发脑机接口互动游戏 等趣味化形式，将技术与教育场景深度融合，针对性培养青少年的专注力，推动脑机技术在智慧教育领域 的落地应用。公司脑机业务预计于 2026年 3月推出原型机。此外公司与国际非侵入式脑机接口技术巨头 NeuroSky（神念科技）达成战略合作，双方将成立合资企业，脑机接口与多模态生物识别技术的深度融 合进入新阶段。双方将共同构建"芯片+情绪云+产业生态"的创新架构，加速脑机接口技术的全球战略布 局。 问：公司现金流良好，是 ...

证券代码：301330 证券简称：熵基科技 熵基科技股份有限公司投资者关系活动记录表 编号：2025-11 | 投资者关系活 | 特定对象调研 业绩说明会 新闻发布会 | 分析师会议 | 媒体采访 | | --- | --- | --- | --- | | 动类别 | 路演活动 | 现场参观 | 其他（反路演） | | 参与单位名称 | 中邮证券、建信基金、招商信诺、汐泰投资 | | | | 时间 | 年 月 日 2025 11 17 | 15:30-16:30 | | | 地点 | 熵基科技会议室、线上会议 | | | | | 副总经理、董事会秘书 郭艳波 | | | | 上市公司接待 人员姓名 | 投资总监 陈川 | | | | | 智能创新研究院院长 仲崇亮 | | | | | 公司董事会秘书首先向投资者介绍了公司主要情况，具体如下： | | | | | 熵基科技成立于 2007 年，是一家以 认知为核心驱动的全球领先的智能空间进化 | | AI | | | 服务商。我们运用多模态 BioCV（计算机视觉与生物识别）与 认知空间计算技术， AI | | | | | 构建全要素感知体系，推 ...

Core Insights - Entropy Technology (301330) has announced a strategic partnership with NeuroSky to establish a joint venture focused on integrating "chip + emotion cloud + industrial ecosystem" in the field of brain-computer interfaces and multimodal biometric recognition [1][2] - The collaboration aims to leverage both companies' technological strengths in multimodal BioCV, AI cognition, and brain-computer interface technologies, creating a complete innovation chain from core chips to algorithm platforms and application scenarios [1][2] Company Overview - NeuroSky is a leading player in the non-invasive brain-computer interface chip market, holding a significant market share and achieving breakthroughs in consumer-grade brainwave monitoring [1] - The company has developed the TGAM series dry electrode brainwave chips, which facilitate "plug-and-play" brainwave detection, lowering the barriers to brain-computer interface technology [1] - NeuroSky's innovations include the world's smallest electrocardiogram sensor, enabling widespread applications in emotion, fatigue, and sleep monitoring [1] Product Development - Entropy Technology has been focusing on multimodal BioCV and AIoT, creating an integrated ecosystem of "hardware + software + services" through its subsidiary, Entropy Brain Technology [2] - Recent product launches include brain rings, brain-controlled drones, brainwave safety helmets, and attention enhancement systems, providing mature hardware and service capabilities for technology implementation [2] Innovation Focus - The partnership will concentrate on two main areas: developing next-generation edge brain-computer interface algorithm chips that integrate various emotional and behavioral algorithms, and advancing mixed biometric recognition and brain signal collaborative analysis [2] - The emotional recognition capabilities will cover three core dimensions: optimistic emotions, negative emotions, and behavioral emotions, enabling detailed identification of fatigue, anxiety, stress, relaxation, happiness, alertness, and empathy [2] Vision and Goals - The chairman of Entropy Technology emphasized the company's commitment to a harmonious coexistence of technology and humanity, aiming to create a new era of emotional perception intelligence through the collaboration with NeuroSky [2] - NeuroSky's CEO highlighted the alignment of both companies' missions to promote the widespread application of brain-computer interface technology, aiming to enhance user experiences in safety management, health, and productivity [2]